83027-0116 NDC - METAB (CALCAREA SULPHURICA, KALI MURIATICUM, KALI PHOSPHORICUM, KALI SULPHURICUM, NATRUM MURIATICUM, NATRUM PHOSPHORICUM, NATRUM SULPHURICUM, CEREBELLUM (SUIS), GALLBLADDER (BOVINE), HEART (BOVINE), HEPAR (BOVINE), HYPOTHALAMUS SUIS, INTESTINE (SUIS), KIDNEY (BOVINE), LUNG (BOVINE), MEDULLA OSSIS SUIS, PANCREAS SUIS, PINEAL GLAND (SUIS), RECTAL MUCOSA (SUIS), SPLEEN (BOVINE), STOMACH (SUIS), THYMUS (OVINE), THYROIDINUM (BOVINE), URINARY BLADDER (SUIS), PITUITARUM POSTERIUM (BOVINE), ACETYL COENZYME A,)

Drug Information

Product NDC: 83027-0116

Proprietary Name: Metab

Non Proprietary Name: Calcarea Sulphurica, Kali Muriaticum, Kali Phosphoricum, Kali Sulphuricum, Natrum Muriaticum, Natrum Phosphoricum, Natrum Sulphuricum, Cerebellum (Suis), Gallbladder (Bovine), Heart (Bovine), Hepar (Bovine), Hypothalamus Suis, Intestine (Suis), Kidney (Bovine), Lung (Bovine), Medulla Ossis Suis, Pancreas Suis, Pineal Gland (Suis), Rectal Mucosa (Suis), Spleen (Bovine), Stomach (Suis), Thymus (Ovine), Thyroidinum (Bovine), Urinary Bladder (Suis), Pituitarum Posterium (Bovine), Acetyl Coenzyme A,

Active Ingredient(s):
  • 12 [hp_X]/mL ACETYL COENZYME A;
  • 16 [hp_X]/mL ACONITIC ACID;
  • 12 [hp_X]/mL ALANINE;
  • 12 [hp_X]/mL ANHYDROUS CITRIC ACID;
  • 12 [hp_X]/mL ARGININE;
  • 12 [hp_X]/mL ASPARAGINE;
  • 12 [hp_X]/mL ASPARTIC ACID;
  • 6 [hp_X]/mL BEEF HEART;
  • 6 [hp_X]/mL BEEF KIDNEY;
  • 6 [hp_X]/mL BEEF LIVER;
  • 6 [hp_X]/mL BEEF LUNG;
  • 6 [hp_X]/mL BOS TAURUS GALLBLADDER;
  • 12 [hp_X]/mL BOS TAURUS PARATHYROID GLAND;
  • 8 [hp_X]/mL BOS TAURUS PITUITARY GLAND, POSTERIOR;
  • 6 [hp_X]/mL BOS TAURUS SPLEEN;
  • 12 [hp_X]/mL CALCIUM FLUORIDE;
  • 6 [hp_X]/mL CALCIUM SULFATE ANHYDROUS;
  • 12 [hp_X]/mL CYSTEINE;
  • 6 [hp_Q]/mL DIBASIC POTASSIUM PHOSPHATE;
  • 12 [hp_X]/mL FERROSOFERRIC PHOSPHATE;
  • 12 [hp_X]/mL FUMARIC ACID;
  • 12 [hp_X]/mL GLUTAMIC ACID;
  • 12 [hp_X]/mL GLUTAMINE;
  • 12 [hp_X]/mL GLYCINE;
  • 30 [hp_X]/mL HERRING SPERM DNA;
  • 12 [hp_X]/mL HISTIDINE;
  • 12 [hp_X]/mL ISOLEUCINE;
  • 6 [hp_X]/mL LAMB;
  • 12 [hp_X]/mL LEUCINE;
  • 12 [hp_X]/mL LYSINE;
  • 12 [hp_X]/mL MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE;
  • 12 [hp_X]/mL MALIC ACID;
  • 12 [hp_X]/mL METHIONINE;
  • 12 [hp_X]/mL OXOGLURIC ACID;
  • 12 [hp_X]/mL PHENYLALANINE;
  • 6 [hp_X]/mL PORK INTESTINE;
  • 6 [hp_X]/mL POTASSIUM CHLORIDE;
  • 6 [hp_X]/mL POTASSIUM SULFATE;
  • 12 [hp_X]/mL PROLINE;
  • 30 [hp_X]/mL SACCHAROMYCES CEREVISIAE RNA;
  • 12 [hp_X]/mL SERINE;
  • 12 [hp_X]/mL SILICON DIOXIDE;
  • 6 [hp_X]/mL SODIUM CHLORIDE;
  • 6 [hp_X]/mL SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE;
  • 6 [hp_X]/mL SODIUM SULFATE;
  • 12 [hp_X]/mL SUCCINIC ACID;
  • 6 [hp_X]/mL SUS SCROFA BONE MARROW;
  • 6 [hp_X]/mL SUS SCROFA CEREBELLUM;
  • 6 [hp_X]/mL SUS SCROFA HYPOTHALAMUS;
  • 6 [hp_X]/mL SUS SCROFA PANCREAS;
  • 6 [hp_X]/mL SUS SCROFA PINEAL GLAND;
  • 6 [hp_X]/mL SUS SCROFA RECTAL MUCOSA;
  • 6 [hp_X]/mL SUS SCROFA STOMACH;
  • 6 [hp_X]/mL SUS SCROFA URINARY BLADDER;
  • 12 [hp_X]/mL THREONINE;
  • 6 [hp_X]/mL THYROID, BOVINE;
  • 12 [hp_X]/mL TRIBASIC CALCIUM PHOSPHATE;
  • 12 [hp_X]/mL TYROSINE;
  • 12 [hp_X]/mL VALINE


Administration Route(s): ORAL

Dosage Form(s): SPRAY

Pharmacy Class(es):
  • Acidifying Activity [MoA];
  • Allergens [CS];
  • Allergens [CS];
  • Amino Acid [EPC];
  • Amino Acid [EPC];
  • Amino Acids [CS];
  • Amino Acids [CS];
  • Anti-coagulant [EPC];
  • Blood Coagulation Factor [EPC];
  • Blood Coagulation Factor [EPC];
  • Calcium Chelating Activity [MoA];
  • Calcium [CS];
  • Calcium [CS];
  • Calculi Dissolution Agent [EPC];
  • Calculi Dissolution Agent [EPC];
  • Cations;
  • Divalent [CS];
  • Cations;
  • Divalent [CS];
  • Cell-mediated Immunity [PE];
  • Cell-mediated Immunity [PE];
  • Decreased Coagulation Factor Activity [PE];
  • Dietary Proteins [CS];
  • Dietary Proteins [CS];
  • Increased Coagulation Factor Activity [PE];
  • Increased Coagulation Factor Activity [PE];
  • Increased Histamine Release [PE];
  • Increased Histamine Release [PE];
  • Increased Large Intestinal Motility [PE];
  • Increased Large Intestinal Motility [PE];
  • Increased Large Intestinal Motility [PE];
  • Inhibition Large Intestine Fluid/Electrolyte Absorption [PE];
  • Inhibition Large Intestine Fluid/Electrolyte Absorption [PE];
  • Inhibition Large Intestine Fluid/Electrolyte Absorption [PE];
  • Inhibition Small Intestine Fluid/Electrolyte Absorption [PE];
  • Magnesium Ion Exchange Activity [MoA];
  • Meat Proteins [EXT];
  • Meat Proteins [EXT];
  • Non-Standardized Food Allergenic Extract [EPC];
  • Non-Standardized Food Allergenic Extract [EPC];
  • Osmotic Activity [MoA];
  • Osmotic Activity [MoA];
  • Osmotic Activity [MoA];
  • Osmotic Laxative [EPC];
  • Osmotic Laxative [EPC];
  • Osmotic Laxative [EPC];
  • Phosphate Binder [EPC];
  • Phosphate Binder [EPC];
  • Phosphate Chelating Activity [MoA];
  • Phosphate Chelating Activity [MoA];
  • Potassium Compounds [CS];
  • Potassium Compounds [CS];
  • Potassium Salt [EPC];
  • Potassium Salt [EPC];
  • Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]

Labeler Information

Labeler Name: Nutritional Specialties, Inc.
Product Type: HUMAN OTC DRUG
FDA Application Number:
Marketing Category: UNAPPROVED HOMEOPATHIC
Start Marketing Date:10/9/2023

Package Information

No. Package Code Package Description Billing Unit
183027-0116-160 mL in 1 BOTTLE, SPRAY (83027-0116-1)

NDC Record

Field Name Field Value Definition
PRODUCT NDC83027-0116The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC.
PRODUCT TYPE NAMEHUMAN OTC DRUGIndicates the type of product, such as Human Prescription Drug or Human Over the Counter Drug. This data element matches the “Document Type” field of the Structured Product Listing.
PROPRIETARY NAMEMetabThe proprietary name also known as the trade name is the name of the product chosen by the medication labeler for marketing purposes.
NON PROPRIETARY NAMECalcarea Sulphurica, Kali Muriaticum, Kali Phosphoricum, Kali Sulphuricum, Natrum Muriaticum, Natrum Phosphoricum, Natrum Sulphuricum, Cerebellum (Suis), Gallbladder (Bovine), Heart (Bovine), Hepar (Bovine), Hypothalamus Suis, Intestine (Suis), Kidney (Bovine), Lung (Bovine), Medulla Ossis Suis, Pancreas Suis, Pineal Gland (Suis), Rectal Mucosa (Suis), Spleen (Bovine), Stomach (Suis), Thymus (Ovine), Thyroidinum (Bovine), Urinary Bladder (Suis), Pituitarum Posterium (Bovine), Acetyl Coenzyme A,The non-proprietary name is sometimes called the generic name. The generic name usually includes the active ingredient(s) of the product.
DOSAGE FORM NAMESPRAYThe translation of the dosage form Code submitted by the firm.
ROUTE NAMEORALThe translation of the route code submitted by the firm, indicating route of administration.
START MARKETING DATE10/9/2023This is the date that the labeler indicates was the start of its marketing of the drug product.
MARKETING CATEGORY NAMEUNAPPROVED HOMEOPATHICProduct types are broken down into several potential Marketing Categories, such as NDA/ANDA/BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.
LABELER NAMENutritional Specialties, Inc.Name of Company corresponding to the labeler code segment of the Product NDC.
SUBSTANCE NAMEACETYL COENZYME A; ACONITIC ACID; ALANINE; ANHYDROUS CITRIC ACID; ARGININE; ASPARAGINE; ASPARTIC ACID; BEEF HEART; BEEF KIDNEY; BEEF LIVER; BEEF LUNG; BOS TAURUS GALLBLADDER; BOS TAURUS PARATHYROID GLAND; BOS TAURUS PITUITARY GLAND, POSTERIOR; BOS TAURUS SPLEEN; CALCIUM FLUORIDE; CALCIUM SULFATE ANHYDROUS; CYSTEINE; DIBASIC POTASSIUM PHOSPHATE; FERROSOFERRIC PHOSPHATE; FUMARIC ACID; GLUTAMIC ACID; GLUTAMINE; GLYCINE; HERRING SPERM DNA; HISTIDINE; ISOLEUCINE; LAMB; LEUCINE; LYSINE; MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE; MALIC ACID; METHIONINE; OXOGLURIC ACID; PHENYLALANINE; PORK INTESTINE; POTASSIUM CHLORIDE; POTASSIUM SULFATE; PROLINE; SACCHAROMYCES CEREVISIAE RNA; SERINE; SILICON DIOXIDE; SODIUM CHLORIDE; SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE; SODIUM SULFATE; SUCCINIC ACID; SUS SCROFA BONE MARROW; SUS SCROFA CEREBELLUM; SUS SCROFA HYPOTHALAMUS; SUS SCROFA PANCREAS; SUS SCROFA PINEAL GLAND; SUS SCROFA RECTAL MUCOSA; SUS SCROFA STOMACH; SUS SCROFA URINARY BLADDER; THREONINE; THYROID, BOVINE; TRIBASIC CALCIUM PHOSPHATE; TYROSINE; VALINEAn active ingredient is the substance responsible for the medicinal effects of a product specified by the substance's molecular structure or if the molecular structure is not known, defined by an unambiguous definition that identifies the substance. Each active ingredient name is the preferred term of the UNII code submitted.
ACTIVE NUMERATOR STRENGTH12; 16; 12; 12; 12; 12; 12; 6; 6; 6; 6; 6; 12; 8; 6; 12; 6; 12; 6; 12; 12; 12; 12; 12; 30; 12; 12; 6; 12; 12; 12; 12; 12; 12; 12; 6; 6; 6; 12; 30; 12; 12; 6; 6; 6; 12; 6; 6; 6; 6; 6; 6; 6; 6; 12; 6; 12; 12; 12 
ACTIVE INGRED UNIT[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_Q]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL 
PHARM CLASSESAcidifying Activity [MoA], Allergens [CS], Allergens [CS], Amino Acid [EPC], Amino Acid [EPC], Amino Acids [CS], Amino Acids [CS], Anti-coagulant [EPC], Blood Coagulation Factor [EPC], Blood Coagulation Factor [EPC], Calcium Chelating Activity [MoA], Calcium [CS], Calcium [CS], Calculi Dissolution Agent [EPC], Calculi Dissolution Agent [EPC], Cations, Divalent [CS], Cations, Divalent [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Decreased Coagulation Factor Activity [PE], Dietary Proteins [CS], Dietary Proteins [CS], Increased Coagulation Factor Activity [PE], Increased Coagulation Factor Activity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Meat Proteins [EXT], Meat Proteins [EXT], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Food Allergenic Extract [EPC], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Phosphate Binder [EPC], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA], Phosphate Chelating Activity [MoA], Potassium Compounds [CS], Potassium Compounds [CS], Potassium Salt [EPC], Potassium Salt [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE] 

Download Record

Download this NDC record in Text format: Export

Download this NDC record in Excel (CSV) format: Export

Download this NDC record in XML format: Export

This page was last updated on: 10/12/2023